These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 36964545

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Genetic alterations in papillary thyroid carcinoma and hashimoto thyroiditis: An analysis of hOGG1 loss of heterozygosity.
    Royer MC, Zhang H, Fan CY, Kokoska MS.
    Arch Otolaryngol Head Neck Surg; 2010 Mar; 136(3):240-2. PubMed ID: 20231640
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
    Sakiz D, Sencar ME, Calapkulu M, Ozturk Unsal I, Aktas L, Ucan B, Ozbek M, Cakal E.
    Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
    [Abstract] [Full Text] [Related]

  • 26. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
    Wang Y, Zheng J, Hu X, Chang Q, Qiao Y, Yao X, Zhou X.
    Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.
    Cai YF, Wang QX, Ni CJ, Guo GL, Li Q, Wang OC, Wu L, Du HY, You J, Zhang XH.
    Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Risk factors stratifying malignancy of nodules in contralateral thyroid lobe in patients with pre-operative ultrasound indicated unilateral papillary thyroid carcinoma: A retrospective analysis from single centre.
    Lv T, Zhu C, Di Z.
    Clin Endocrinol (Oxf); 2018 Feb; 88(2):279-284. PubMed ID: 29083503
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
    Ni Y, Wang T, Wang X, Tian Y, Wei W, Liu Q.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr 25; 51(2):225-232. PubMed ID: 36161301
    [Abstract] [Full Text] [Related]

  • 33. Hashimoto thyroiditis coexistent with papillary thyroid carcinoma.
    Cipolla C, Sandonato L, Graceffa G, Fricano S, Torcivia A, Vieni S, Latteri S, Latteri MA.
    Am Surg; 2005 Oct 25; 71(10):874-8. PubMed ID: 16468540
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE, Serdarevic N, Hurduc AE, Stanciu MM.
    Scand J Clin Lab Invest; 2015 Nov 25; 75(7):539-48. PubMed ID: 26305420
    [Abstract] [Full Text] [Related]

  • 37. Clinical relationship between Hashimoto's thyroiditis and papillary thyroid cancer.
    Ahn D, Heo SJ, Park JH, Kim JH, Sohn JH, Park JY, Park SK, Park J.
    Acta Oncol; 2011 Nov 25; 50(8):1228-34. PubMed ID: 21871002
    [Abstract] [Full Text] [Related]

  • 38. Surgical management of papillary thyroid carcinoma coexisting with Hashimoto's disease: a single-center retrospective cohort study.
    Zhang D, Wu J, Chen L.
    Front Endocrinol (Lausanne); 2024 Nov 25; 15():1383945. PubMed ID: 39170744
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.